Yinling Hu

7PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 28, 2025
Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1.

Se-Young Park, Kyuwon Son, Jiwoo Kim

|Feb 05, 2022
IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.

Na-Young Song, Xin Li, Buyong Ma

|Nov 23, 2021
Lymph node formation and B cell homeostasis require IKK-α in distinct endothelial cell-derived compartments.

Kelly A McCorkell, Nipun Jayachandran, Michelle D Cully

Pageof 2